Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Bolignano

Showing results (151-160 of 177) with videos related to

Pageof 18
Sort By:
Medicina (Kaunas, Lithuania)|February 26, 2025
MOTS-c Levels and Sarcopenia Risk in Chronic Peritoneal Dialysis Patients: A Pilot StudyMariateresa Zicarelli, Marta Greco, Stefanos Roumeliotis, et al.
Urologic Oncology|February 17, 2009
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R)Davide Bolignano, Maria Antonietta Medici, Giuseppe Coppolino, et al.
Journal of Nephrology|July 14, 2020
Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patientsDavide Bolignano, Marta Greco, Valentina Arcidiacono, et al.
International Urology and Nephrology|August 15, 2020
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patientsDavide Bolignano, Marta Greco, Valentina Arcidiacono, et al.
Clinical Kidney Journal|May 8, 2023
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patientsDavide Bolignano, Marta Greco, Pierangela Presta, et al.
Cardiorenal Medicine|March 18, 2026
Circulating Humanin Improves the Prognostic Accuracy of Cardiovascular Risk Models in Chronic Hemodialysis PatientsDavide Bolignano, Marta Greco, Sara Pugliese, et al.
Diagnostics (Basel, Switzerland)|June 28, 2023
A Rare Complication of Ascariasis: A Case of Acute Interstitial NephritisNazareno Carullo, Francesca Divenuto, Nadia Marascio, et al.
Blood Purification|August 7, 2024
The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort StudyDavide Bolignano, Marta Greco, Pierangela Presta, et al.
Frontiers in Medicine|August 16, 2023
Hyperkalemia in CKD: an overview of available therapeutic strategiesDavide Costa, Gemma Patella, Michele Provenzano, et al.
International Urology and Nephrology|April 22, 2020
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitusValeria Cernaro, Saverio Loddo, Vincenzo Macaione, et al.
Pageof 18

Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
Medicina (Kaunas, Lithuania)|February 26, 2025
MOTS-c Levels and Sarcopenia Risk in Chronic Peritoneal Dialysis Patients: A Pilot StudyMariateresa Zicarelli, Marta Greco, Stefanos Roumeliotis, et al.
Urologic Oncology|February 17, 2009
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R)Davide Bolignano, Maria Antonietta Medici, Giuseppe Coppolino, et al.
Journal of Nephrology|July 14, 2020
Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patientsDavide Bolignano, Marta Greco, Valentina Arcidiacono, et al.
International Urology and Nephrology|August 15, 2020
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patientsDavide Bolignano, Marta Greco, Valentina Arcidiacono, et al.
Clinical Kidney Journal|May 8, 2023
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patientsDavide Bolignano, Marta Greco, Pierangela Presta, et al.
Cardiorenal Medicine|March 18, 2026
Circulating Humanin Improves the Prognostic Accuracy of Cardiovascular Risk Models in Chronic Hemodialysis PatientsDavide Bolignano, Marta Greco, Sara Pugliese, et al.
Diagnostics (Basel, Switzerland)|June 28, 2023
A Rare Complication of Ascariasis: A Case of Acute Interstitial NephritisNazareno Carullo, Francesca Divenuto, Nadia Marascio, et al.
Blood Purification|August 7, 2024
The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort StudyDavide Bolignano, Marta Greco, Pierangela Presta, et al.
Frontiers in Medicine|August 16, 2023
Hyperkalemia in CKD: an overview of available therapeutic strategiesDavide Costa, Gemma Patella, Michele Provenzano, et al.
International Urology and Nephrology|April 22, 2020
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitusValeria Cernaro, Saverio Loddo, Vincenzo Macaione, et al.
Pageof 18